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Cerebral ischemia (CI) can induce loss of hippocampal neurons, causing cognitive dysfunction such as
learning and memory deﬁcits. In adult mammals, the hippocampal dentate gyrus contains neural stem
cells (NSCs) that continuously generate newborn neurons and integrate into the pre-existing networks
throughout life, which may ameliorate cognitive dysfunction following CI. Recent studies have demon-
strated that recombinant human thioredoxin-1 (rhTrx-1) could promote proliferation of human adipose
tissue-derived mesenchymal stem cells and angiogenesis. To investigate whether rhTrx-1 also regulates
hippocampal neurogenesis following CI and its underlying mechanisms, adult mice were subjected to
bilateral common carotid arteries occlusion (BCCAO) to induce CI and treated with rhTrx-1 before
reperfusion. Mice treated with rhTrx-1 showed shortened escape latencies in Morris water maze by 30
days and improvements in spatial memory demonstrated by probe trial test. Enhanced NSCs prolifera-
tion was observed at day 14, indicated by BrdU and Ki67 immunostaining. Doublecortin (DCX)þ cells
were also signiﬁcantly increased following rhTrx-1 treatment. Despite increases in BrdUþ/NeuNþ cells by
day 30, the double-labeling to total BrdUþ ratio was not affected by rhTrx-1 treatment. The promotive
effects of rhTrx-1 on NSCs proliferation and differentiation were further conﬁrmed in in vitro assays.
Western blot revealed increased ERK1/2 phosphorylation after rhTrx-1 treatment, and the ERK inhibitor
U0126 abrogated the effects of rhTrx-1 on NSCs proliferation. These results provide initial evidence that
rhTrx-1 effects neurogenesis through the ERK signaling pathway and are beneﬁcial for improving spatial
learning and memory in adult mice following global CI.
 2013 The Authors. Published by Elsevier Ltd.Open access under CC BY-NC-ND license.1. Introduction
Cerebral ischemic (CI) and neurodegenerative diseases can
induce hippocampal neuron loss of varying severity which are
pivotally implicated in the deﬁciencies of spatial learning and
memory (Bendel et al., 2005; Chen et al., 2000; Hartman et al.,
2005; West et al., 1994). Although persistent progenitor cell: þ86 83244986.
: þ86 2983244986.
), mzkxlz@126.com, lxiong@
r Ltd.Open access under CC BY-NC-NDproliferation and neurogenesis commonly follow ischemic periods
in the forebrain subventricular zone and hippocampal dentate gy-
rus (DG), a phenomenon that has been well documented in rodent
models, the deﬁnite role of neurogenesis following CI remains
controversial.
Neurogenesis in response to ischemic neuron loss may be a
result of neural stem cells (NSCs) participation in the endogenous
repair processes of the adult mammalian brain (Okano et al., 2007).
New neurons have been detected in the injured area of previously
ischemic tissues, where these new cells were functionally inte-
grated into existing cerebral circuits (Lichtenwalner and Parent,
2006). Conversely, neurogenesis has been suppressed using X-ray
irradiation prior to bilateral common carotid arteries occlusion
(BCCAO) in gerbil models, resulting in severe spatial learning and
memory deﬁcits following ischemia (Raber et al., 2004). These
ﬁndings underscore the importance of neurogenesis in functional
recovery. Enhanced hippocampal neurogenesis also facilitates long- license.
Fig. 1. Graphic presentation of the experimental protocol. The mice brain ischemia
model was induced by BCCAO for 20 min. Experimental mice were randomized to
receive either vehicle (0.1 M PBS, pH 7.4; i.p.) or an equal volume of rhTrx-1 (3 mg/kg;
i.p.) 10 min before reperfusion. BrdU (100 mg/kg; i.p) was administrated daily for 4
consecutive days from 9 to 12 days after ischemia, and mice were then sacriﬁced for
neurogenesis assays at 14 and 30 days post-ischemia. Behavioral testing was con-
ducted 30 days after ischemia. Sham-operated animals were also injected with BrdU
after sham surgeries and subjected to behavioral testing prior to sacriﬁce.
Table 1
Physiologic parameters.
T (C) pH PaO2 (mmHg) PaCO2 (mmHg)
Onset of BCCAO
Sham 37.0  0.12 7.39  0.02 192.4  0.8 37.5  0.6
CI þ vehicle 36.9  0.20 7.40  0.02 193.6  1.1 38.1  0.3
CI þ rhTrx-1 37.1  0.18 7.38  0.04 189.5  0.7 36.3  0.4
Onset of reperfusion
Sham 37.1  0.15 7.41  0.02 196.2  0.5 39.1  0.7
CI þ vehicle 37.0  0.11 7.40  0.03 190.8  1.6 38.5  0.6
CI þ rhTrx-1 37.1  0.13 9.48  0.04 192.9  1.4 37.6  0.5
Data was shown as mean  SD. CI þ vehicle and CI þ rhTrx-1 mice were induced by
transient BCCAO for 20 min, while sham-operated mice were treated with the same
surgical procedure, with the exception of occlusion. BCCAO ¼ bilateral common
carotid arteries occlusion; PaO2 ¼ arterial oxygen tension; PaCO2 ¼ arterial carbon
dioxide tension.
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et al., 2002; Deng et al., 2010; Schmidt-Hieber et al., 2004).
Therefore, facilitation of endogenous neurogenesis may be a
promising regenerative strategy for ischemic stroke treatment.
Both direct and indirect approaches have been developed to
stimulate proliferation and neurogenesis, attenuate infarct volume,
and improve neurological deﬁcits in the ischemic stroke model.
Thioredoxin (Trx), a 12-kD oxidoreductase enzyme containing a
dithiol-disulﬁde active site, is a redox-sensitive molecule with
pleiotropic cellular effects involved in regulation of proliferation,
redox states, and anti-apoptosis (Mukherjee and Martin, 2008).
Two isoforms of Trx exist in mammalian cells. Cytosolic Trx-1,
which can be translocated into the nucleus under certain circum-
stances, is the dominant form, and mitochondrial Trx-2 occurs
relatively less frequently (Dunn et al., 2010). Endogenous Trx-1
production is induced by ischemia of brain tissues, where it is
responsible for alleviation of oxidative damage. Moreover, exoge-
nously administered recombinant human Trx-1 (rhTrx-1) can
penetrate the blood brain barrier and exert a neuroprotective effect,
as demonstrated in the middle cerebral artery occlusion (MCAO)
model (Hattori et al., 2004). In addition to its role as an antioxidant,
rhTrx-1 has also been reported to promote proliferation of human
adipose tissue-derived mesenchymal stem cells and angiogenesis
(Song et al., 2011; Welsh et al., 2002).
While the neuroprotective role of rhTrx-1 on injured neurons is
well-established, rhTrx-1 may also promote neurogenesis and
facilitate long-term recovery following CI. In order to investigate
this hypothesis, the current study applied the BCCAO mouse model
to investigate the role of rhTrx-1 in neurogenesis and its potential
effect on cognitive deﬁcits in learning andmemory following global
CI. In addition, the mechanisms associated with rhTrx-1 were
tentatively explored.
2. Materials and methods
2.1. Animals and experimental design
Male C57BL/6J mice weighing 25e30 g purchased from the
Laboratory Animal Center of the Fourth Military Medical University
(Shaanxi, China) were used in the current in vivo studies. All
experimental protocols complied with the Guide for the Care and
Use of Laboratory Animals published by the National Institutes of
Health (NIH). All experiments were also conducted in accordance
with the Fourth Military Medical University Committee on Animal
Care.
Mice were provided ad libitum access to food and water, and
mice were housed in a temperature-controlled room with 12 h
lightedark cycles. Experimental procedures for in vivo studies are
described in Fig. 1. Brieﬂy, mice were randomized into 3 groups: the
sham-operated group, the cerebral ischemia plus vehicle
(CI þ Vehicle) group, and the cerebral ischemia plus rhTrx-1
(CI þ rhTrx-1) group. Mice of each group were then equally
divided into two subgroups for cognitive function evaluation and
neurogenesis detection, respectively.
Mice of the CI þ rhTrx-1 group were subjected to transient
BCCAO for 20min and intraperitoneal (i.p.) administration of rhTrx-
1 containing 3mg/kg of the cytosolic form of Trx (Sigma-Aldrich, St.
Louise, MO) 10 min before reperfusion, according to the previously
published method (Hattori et al., 2004; Tao et al., 2006). The
CI þ Vehicle group was simultaneously treated with similar BCCAO
and i.p. administration of an equal volume of a 0.1 M phosphate
buffered saline (PBS) solution as an inert vehicle (pH 7.4).
For neurogenesis analysis, mice were treated with daily 100 mg/
kg i.p. injections of 5-bromo-20-deoxyuridine (BrdU; Sigma-
Aldrich, St. Louis, MO) for 4 consecutive days, during the peak ofcell proliferation, or from days 9e12 after rhTrx-1 or vehicle
treatment, according to the previously reported method (Bernabeu
and Sharp, 2000; Liu et al., 1998). Mice of the sham-operated group
also underwent i.p. injection of BrdU following sham surgeries. All
the mice were sacriﬁced by days 14 and 30 and tissues were
collected for further immunohistochemical study. Behavioral tests
were performed 30 days after ischemia. NSCs were harvested from
the fetal brain of pregnant Sprague-Dawley rats under deep anes-
thesia induced by treatment with 300 mg/kg i.p. chloral hydrate
between embryonic days 14.5 and 16.5.
2.2. Transient forebrain cerebral ischemia
Mice were anesthetized with 2% isoﬂurane using a facemask,
and CI was induced by transient BCCAO for 20 min, as described
previously (Homi et al., 2003; Tajiri et al., 2004; Wu et al., 2001).
Sham-operated animals were treated with the same surgical pro-
cedure, with the exception of occlusion. A PeriFlux System 5000
laser Doppler ﬂowmeter (Perimed, Stockholm, Sweden) was used
to measure regional cerebral blood ﬂow (rCBF) from the start of
anesthetic induction to 5 min after reperfusion (Olsson et al., 2004;
Yoshioka et al., 2011). In the current experimental model, only re-
sults frommice with a mean CBF successfully reduced to 10% of the
pre-ischemic value were used in subsequent data analysis. Rectal
temperature was maintained at 37.5  0.5 C with a heating lamp
until mice were revived.
2.3. Arterial blood gas determination
Left femoral arterial catheters were placed in separate groups of
sham, CIþ Vehicle and CIþ rhTrx-1 groups (n¼ 5 in each group) to
determine the arterial blood gas (Table. 1). About 0.2 ml of blood
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reperfusion. After the ﬁnal blood sample taken, blood gas was
immediately analyzed (Rapidlab 1260, Bayer HealthCare, Uxbridge,
United Kingdom).
2.4. Behavioral tests
Experimental C57BL/6J mice were subjected behavioral tests 30
days after ischemia. To minimize potential stress-related effects
from previous behavioral performance testing, mice were ﬁrst
tested in the open ﬁeld and then in the water maze, according to
the previously published method (Raber et al., 2004).
2.4.1. Open-ﬁeld test
Spontaneous locomotor activity was evaluated using an open-
ﬁeld test. Mice were individually placed in the center zone of an
open ﬁeld apparatus (50  50  40 cm). All movements were
traced, and data were collected by video for 15 min after a 2 min
habituation period. Total distances traveled and percentage of time
spent in the 30  30 cm square center zone of the apparatus was
analyzed by an automatic analyzing system (DigBehav, Jiliang Co.
Ltd., Shanghai, China) (Miki et al., 2009; Miyakawa et al., 2001). The
apparatus was cleaned with water after each trial.
2.4.2. Morris Water Maze (MWM) test
MWM was employed to assess mouse spatial learning and
memory according to previously published methods (Morris, 1984;
Rehni et al., 2009). The maze consisted of a large circular pool
(150 cm in diameter, 45 cm in height, ﬁlled to a depth of 30 cm
with water at 28  1 C). Water was made opaque with a white
dye. A painted white platform (10 cm2) was submerged and placed
in the center of the target quadrant at 1 cm below the surface of
water, providing the escape area. The position of the platform was
maintained unaltered throughout the training session. Mice were
allowed 4 training trials per day for 5 consecutive days. During
each trial, mice were allowed to start from a random location in
each of 4 quadrants. Mice were placed in a starting position in
which its head was facing the wall, and the hidden platform was
maintained in a ﬁxed location. Each mouse was allowed a
maximum of 60 s to ﬁnd the submerged platform and rest for 30 s.
If the mouse failed to ﬁnd the hidden platform within 60 s, it was
manually guided to the platform and allowed to rest for 30 s. The
escape latency to ﬁnd the hidden platform and the total path
length to the platform were recorded. On the day 6, mice were
subjected to a 60 s probe trial in which the platform was removed.
The percentage of time spent in the target quadrant was consid-
ered to reﬂect memory retention, as previously described (Lai
et al., 2007). A digital video camera was positioned directly
above the water maze, enabling full collection of swim activity in
the different quadrants, and the data feed was attached to a
computer using DigBehav System (Jiliang Software Co., Shanghai,
China) software (Peng et al., 2010).
2.5. Tissue preparations and immunohistochemistry
Mice were subjected to deep anesthesia with 300 mg/kg i.p.
chloral hydrate and treated with saline followed by a cold 4%
paraformaldehyde during transcardiac perfusion. Brain tissues
were then extracted and post-ﬁxed in 4% paraformaldehyde over-
night at 4 C. After successively inﬁltrated with in 0.1 M PBS con-
taining 20% and 30% sucrose overnight, coronal sections in 12 mm
thicknesses were cut and stored at 20 C until use. For BrdU
immunohistochemistry, brain tissue sections were incubated in HCl
(1 N) for 40 min at 45 C to break open the DNA structure of the
labeled cells, as previously described (Fournier et al., 2012;Wojtowicz and Kee, 2006). Immediately after the acid wash,
borate buffer (0.1 M) was added to the cells. All sections were then
incubated in a blocking solution for 1 h prior incubationwith 1:100
rat-anti-BrdU (Abcam, USA) diluted in PBS at 4 C for 48 h.
Following incubation with the primary antibody, these sections
were treated with 1:100 biotinylated goateanti-rat (Vector, USA) at
room temperature for 2 h followed by treatment with 1:1000
rhodamineeavidin D anti-mouse IgG (Vector, USA) at room tem-
perature for 2 h. For Ki67 (the marker of cell proliferation) and DCX
(donblecortin, the marker of developing, immature neurons)
staining, sections were ﬁrst treated with 1:1000 anti-rabbit Ki67
(Abcam, USA) and 1:2000 anti-rabbit DCX (Abcam, USA) antibodies
at 4 C overnight. After washing in PBS, sections were then incu-
bated in 1:500 Alexa Fluor 488-conjugated donkey anti-rabbit
(Invitrogen, USA) and 1:500 Alexa Fluor 594-conjugated goat
anti-rabbit (Invitrogen, USA) secondary antibodies at room tem-
perature for 4 h. For double immunostaining, sections were incu-
bated with rat anti-BrdU ﬁrst, as described previously. After
treatment with a biotinylated goateanti-rat and Rhodaminee
avidin D, these sections werewashed in PBS and treated with 1:100
mouse anti-NeuN (Chemicon, USA) at 4 C overnight followed by
treatment with 1:500 Alexa Fluor488-conjugated anti-rat IgG
(Invitrogen, USA) at room temperature for 4 h. Finally, sections
were incubated with Hochest 33342 for 10 min at room tempera-
ture to stain cell nuclei.
2.6. Cell culture and drug administration
Embryonic brains between E14.5 and E16.5 were dissected
under a stereomicroscope, and single cell suspensions from the
hippocampus were obtained by mechanical dissociation. Cell
suspensions were primarily plated at a density of 5  105 cells/ml
in 25 cm2 Corning (USA) cell culture ﬂasks using serum free
Dulbecco’s modiﬁed Eagle’s medium (DMEM)/F12 medium con-
taining 20 ng/ml bFGF (human recombinant, Peprotech, 100-18B,
USA), 20 ng/ml EGF (rat recombinant, Peprotech, 400-25, USA), B-
27 and N-2 supplement (Gibco, USA), and penicillin and strep-
tomycin. The resultant neurospheres were harvested and me-
chanically dissociated to produce a single cell suspension for
replating every 6e7 d. All experiments were performed during
the second or third passage, after which single cells were
resuspended. Cells were seeded onto plates or cover clips for 1 h,
and rhTrx-1 was added to the culture medium at variant con-
centrations. The ERK signaling pathway was inhibited by adding
4 mM of U0126 (Sigma-Aldrich, USA) to the medium 0.5 h prior to
rhTrx-1 administration.
2.7. Immunocytochemistry
To verify the identity of NSCs, neurospheres or single cells were
collected and ﬁxed in 4% paraformaldehyde. Frozen sections of the
neurospheres and single cells on the cover slips were incubated
with a mouse anti-nestin antibody (1:500, Abcam, Hong Kong)
overnight at 4 C. Immunolabeling was visualized by an anti-mouse
Alexa Fluor 594-conjugated secondary antibody (1:500,
Invitrogen).
Proliferation assay was performed after NSCs were incubated
with rhTrx-1 for 2 d. rhTrx-1-treated neurospheres were labeled
with 10 mM BrdU for 2 h and then dissociated into single cells and
plated onto poly-L-lysine coated cover clips at a concentration of
2  104 cells per well in 24-well plates. After a 6 h attachment
period, cells were ﬁxed in 4% paraformaldehyde for 45 min. The
ﬁxativewas then removed, and cells were incubated in HCl (1 N) for
30min at 37 C to break open the DNA structure of the labeled cells.
Immediately after acid washing, cells were incubated with borate
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staining experiments, cells were plated onto cover slips at a density
of 2  104 cells per well in 24-well plates and treated with rhTrx-1.
For immunostaining, cells were incubated at 4 C overnight in PBS
supplemented with 1% bovine serum albumin (BSA) and 0.3%
Triton-X100 and either rat-anti-BrdU (1:100, Abcam, USA) or rabbit
anti-Ki67 antibody (1:1000, Abcam, USA). Following incubation
with rat anti-BrdU, cells were treated with 1:100 biotinylated goat
anti-rat IgG (Vector, USA) at room temperature for 2 h followed by
treatment with 1:1000 rhodamineeavidin D anti-mouse IgG
(Vector, USA) at room temperature for 2 h. Following incubation
with Ki67, cells were incubated with a ﬂuorophore-conjugated
secondary antibody (Alexa Fluor 488, 1:500, Invitrogen, USA) for
2 h at room temperature. Cells were further counter-stained using
50 mg/ml propidium iodide (PI, SigmaeAldrich, USA) or DAPI for
nuclei staining. BrdU-labeled and Ki67-positive cells were counted
and normalized to the total cell count.
NSCs were phenotyped 7 days after rhTrx-1 treatment by pro-
tein marker expression. Cells were seeded on poly-D-lysine-coated
cover clips at a density of 3  104 cells/well in DMEM/F12 medium
containing 4% fetal bovine serum (SigmaeAldrich, USA) and treated
with rhTrx-1 for 7 d. After ﬁxation, cells were incubated at 4 C
overnight with the primary antibodies composed of 1:500 mouse
anti-Tuj1 (the marker of differentiated neurons; SigmaeAldrich,
USA) and 1:2000 rabbit anti-GFAP (the marker of differentiated
astrocytes; Millipore, USA) diluted in blocking reagent and then
incubated with 1:500 secondary antibodies (Alexa Fluor 488 orFig. 2. rhTrx-1 facilitated ischemia-induced spatial learning and memory deﬁcits. (A) Escap
speed was observed between the three groups. (C). Percentage of time spent in the target qua
in the center in the open ﬁeld test. Mice were subjected to a sham operation (Sham), BCCAO
1 administration (CI þ rhTrx-1). The MWM test and open ﬁeld test were performed 30 days
followed by a Tukey post-hoc test and expressed as means  S.E.M. from 8 independent an
CI þ Vehicle group.Alexa Fluor 594, Invitrogen, USA) for 2 h at room temperature.
Finally, cells were incubated with DAPI to stain the nuclei.
2.8. Western blot
Cells were collected and lysed with SDS-PAGE sample buffer
composed of 62.5 mM TriseHCl, 2% w/v SDS, 10% glycerol, 50 mM
DTT, and 0.1% w/v bromphenol blue. Insoluble materials were
separated by centrifugation at 12,000 g for 10 min, and the super-
natant was heated at 100 C for 10 min and then cooled on ice for
30 min. Electrophoresis was conducted by SDS-PAGE by using 10%
polyacrylamide in accordance with routine protocols. Then the
proteins in PAGE were transferred onto nitrocellulose membranes
and blocked in blocking solution containing 5% defatted milk
powder, 0.1% Tween-20 in TBS for 1 h at room temperature with
gentle shaking. After being washed in TBS 3 times for 8 min each,
the following primary antibodies were used for incubation over-
night at 4 C: 1:2500 rabbit anti-pERK1/2 (Cell Signaling, USA),
1:2500 rabbit anti-ERK1/2 (Cell Signaling, USA), 1:1000 mouse
anti-pAkt (Cell Signaling, USA), 1:1000 total Akt (Cell Signaling,
USA), 1:1000 rabbit anti-Tuj1 (SigmaeAldrich, USA), 1:5000 rabbit
anti-GFAP (Millipore, USA), and 1:10000 rabbit anti-GAPDH anti-
body (SigmaeAldrich, USA) as a loading control. All membranes
were then washed 3 times in TBS and incubated with peroxidase-
conjugated goat anti-rabbit IgG or peroxidase-conjugated goat
anti-mouse IgG in TBST for 1 h. Immunoreactive bands were
detected using enhanced chemiluminescence (ECL; Amersham, UK)e latency to ﬁnd the hidden platform in MWM testing. (B). No difference in swimming
drant in the probe trial. (D) Total distance traveled in the open ﬁeld test. (E) Time spent
for 20 min with vehicle administration (CI þ Vehicle) and BCCAO for 20 min with rhTrx-
after reperfusion. Data were analyzed by two-way ANOVAwith repeated measurement,
imals (n ¼ 8). #P < 0.05, ##P < 0.01 vs sham-operated group; *P < 0.05, **P < 0.01 vs
L. Tian et al. / Neuropharmacology 77 (2014) 453e464 457and quantiﬁed with Bio-Rad Quantity One (Hercules, CA, USA)
software.
2.9. Statistical analysis and quantiﬁcation
All preparations were analyzed under an FV-1000 laser scanning
confocal microscope (Olympus, USA) and positive cells were
measured using Image-Pro Plus version 6.0 (Media Cybernetics,Fig. 3. rhTrx-1 promoted neurogenesis in the hippocampal dentate gyrus. (A, B) Microphoto
gyrus of each group 14 days after reperfusion. (C, D) Microphotographs and histograms s
reperfusion. (E) Representative confocal microscopic images showing BrdU (red) and Neu
number of BrdUþ/NeuNþ cells (upper) and the percentage of BrdUþ/NeuNþ cells to the total B
by Tukey post-hoc test and expressed as means  S.E.M. from six independent animals (n ¼
group.USA) software. An experimenter blinded to group assignments
counted all proliferating precursors (BrdUþ and Ki67þ cells) in the
entire granule cell layer (GCL). For quantitation of BrdUþ- and
Ki67þ-labeled cells in the dentate gyrus of each mouse brain, every
sixth section of the dorsal hippocampus was processed. Results
were expressed as the number of labeled cells. Cells in the GCL and
adjacent subgranular zone (SGZ) were deﬁned as two-cell body-
wide zones of the hilus along the base of the GCL andwere counted,graphs and histograms showing BrdU (red) and Ki67 (red) positive cells in the dentate
howing DCX (green) positive cells in the dentate gyrus of each group 14 days after
N (green) double-stained cells 30 days after reperfusion. (F) Histograms showing the
rdUþ cells (lower). Scale bar: 50 mm. Data were analyzed by one-way ANOVA, followed
6). #P < 0.05, ##P < 0.01 vs sham-operated group; *P < 0.05, **P < 0.01 vs CI þ Vehicle
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2008). Total numbers of DCX-labeled cells in the DG were counted
under light microscopy for each mouse. DCXþ neurons and granule
cells were counted throughout the section thickness, excluding
cells in the uppermost focal plane (Fuss et al., 2010; Naylor et al.,
2008). For quantiﬁcation of double-labeled cells, the percentage
number of new neurons (60 BrdUþ cells per mouse) was assessed
using confocal microscopy. The percentages of BrdUþ/NeuNþ cells
to the absolute number of BrdUþ cells was calculated to provide a
ratio of newly generated neurons (Jiang et al., 2005).
In the in vitro experiment, BrdU-, Ki67-, Tuj1-, and GFAP-labeled
cells were counted. Results were expressed as a percentage to the
total cells indicated by PI or DAPI staining. At least 3e5 indepen-
dent experiments were performed for each assay.
All data were analyzed using GraphPad Prism (GraphPad, USA)
software. Histological data as well as relevant data from in vivo and
in vitro assays were analyzed by one-way ANOVA followed by
Tukey post-hoc testing in order to investigate the differences be-
tween sham, CI þ Vehicle, and CI þ rhTrx-1 groups at corre-
sponding time intervals. Behavioral testing data were analyzed by
repeated-measure two-way ANOVA, and probe trail testing data
were analyzed by one-way ANOVA followed by Tukey post-hoc
testing. Results were presented as mean  standard error of the
mean (SEM). A P-value of less than 0.05 was considered signiﬁcant
(P < 0.05), and a P-value of less than 0.01 was considered highly
signiﬁcant (P < 0.01).Fig. 4. rhTrx-1 promoted proliferation of cultured NSCs in a dose dependent manner. (A, B)
NSCs after incubation with vehicle and rhTrx-1 of variant concentrations for 48 h. (C) Imm
stained with nestin (red) and then counterstained with DAPI (blue) as the nuclear marker. (
number of dividing cells in rhTrx-1 groups relative to the vehicle group. Scale bar: 50 mm. Da
mean  S.E.M. from 5 wells per treatment condition. *P < 0.05, **P < 0.01 vs Vehicle grou3. Results
3.1. rhTrx-1 ameliorated spatial learning and memory deﬁcits
induced by ischemia
In the Morris Water Maze test, long latent period were initially
required to ﬁnd the platform for all mouse subjects, though this
time decreased with progressive trial number. Sham-operated and
CI þ rhTrx-1 groups showed no signiﬁcant differences in task-
learning abilities and similar latency reduction rates (P > 0.05).
Mice in the CIþ Vehicle group, however, required increased time to
locate the submerged platform compared with times in the rhTrx-1
and sham groups for each training day in MWM testing. Consistent
with these ﬁndings, two-way ANOVA indicated that group and day
exerted signiﬁcant effects on escape latency. At test day 1,
CI þ Vehicle mice required longer times to ﬁnd the platform rela-
tive to the CI þ rhTrx-1 group; however, no statistical difference
was observed (P > 0.05). By days 2e4, the time required to ﬁnd the
platform in the CIþ Vehicle groupwas notably longer than those in
both the sham-operated and CI þ rhTrx-1 groups (Fig. 2A, P < 0.01
at day 1 and 3; P < 0.05 at day 4) groups. Swimming speed during
the test was also evaluated and analyzed by two-way ANOVA,
demonstrating no group or day effects on swimming speed (Fig. 2B,
P > 0.05). In the probe trial test, both sham-operated and
CI þ rhTrx-1 group mice appeared to have learned the task,
demonstrating superior ability to remember the platform locationImmunoﬂuorescence images of BrdU (green)/PI (red) and Ki67 (red)/DAPI (blue) stained
unoﬂuorescence image of single neural cells and a neurosphere that were ﬁxed and
D, E) Quantitation of BrdU and Ki67 positive cells showing a signiﬁcant increase in the
ta were analyzed by one-way ANOVA, followed by Tukey post-hoc test and expressed as
p.
L. Tian et al. / Neuropharmacology 77 (2014) 453e464 459compares to vehicle-treated mice. This effect was evidenced by
signiﬁcantly longer periods of time spent in the target quadrant in
the sham-operated and CI þ rhTrx-1 groups compared to the
CI þ Vehicle group (Fig. 2C, P < 0.05).Fig. 5. rhTrx-1 promoted cultured NSC differentiation into neurons. (A) Immunoﬂuorescenc
vehicle or rhTrx-1 of variant concentrations for 7 days. (B) High magniﬁcation of the image
positive cells to the total DAPI positive cells (left) and the percentage of GFAP positive cells
determined by Western blot. Representative bands and densitometric analysis of Tuj1 (upp
analyzed by one-way ANOVA, followed by Tukey post-hoc test and expressed as mean  STo assess whether reduced activity levels could have contrib-
uted to impairments in MWM performance following ischemia,
experimental mice were tested for open-ﬁeld activity. In the open
ﬁeld test, no signiﬁcant difference in horizontal distance of travel ine images of Tuj1 (red), GFAP (green), and DAPI (blue) stained NSCs after incubation with
s from vehicle and rhTrx-1 (10 mg/ml) groups. (C) Histograms of the percentage of Tuj
to the total DAPI positive cells (right). (D) Expression of Tuj1 and GFAP in each group
er) and GFAP (lower) with GAPDH as the loading control. Scale bar: 50 mm. Data were
.E.M. from 5 wells per treatment condition. *P < 0.05, **P < 0.01 vs Vehicle group.
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P > 0.05). In addition, the number of entries to the central zone of
the open ﬁeld was recorded in order to assess mouse anxiety level.
No signiﬁcant difference was observed in center zone time for any
group (Fig. 2E, P > 0.05).
3.2. rhTrx-1 promoted ischemia-induced neurogenesis in DG
To investigate the effect of rhTrx-1 on proliferation of the neural
stem cells following forebrain ischemia, the cells incorporated with
BrdU and those stained with Ki67 in the DG were counted (Fig. 3A).
At post-ischemic day 14, the number of BrdUþ cells increased
approximately 1.5-fold in the CI þ Vehicle group compared with
the sham-operated group (Fig. 3B; P < 0.05). In addition, admin-
istration of rhTrx-1 signiﬁcantly increased the number of BrdUþ
cells compared with the CIþ Vehicle group (P< 0.01). Similarly, the
CI þ Vehicle group showed increased numbers of Ki67þ cells
(Fig. 3B; P< 0.05) and this number reached approximately 2-fold in
CIþ rhTrx-1 group (P< 0.01). DCX expressionwas used to estimate
cycling precursors of neuronal lineage as well as maturing young
granule cells (Fuss et al., 2010) (Couillard-Despres et al., 2005). The
CI þ rhTrx-1 group demonstrated a signiﬁcant increase in the
number of DCXþ cells in the DG (Fig. 3C, D; P < 0.01).
To estimate the effect of rhTrx-1 on the differentiation of NSCs,
double labeling of BrdU and NeuN was performed 30 days after
ischemia (Fig. 3E). The number of BrdUþ cells in the CI þ rhTrx-1
groupwasmuch larger than that observed in the CIþ Vehicle group
(Fig. 3F; P< 0.01), indicating the survival of themajority of rhTrx-1-
induced new neural cells. Although many BrdUþ cells were still
found in the DG, immunoﬂuorescence staining revealed that the
proportion of BrdUþ/NeuNþ double-labeled cells to total BrdUþ
cells in both the CI þ rhTrx-1 and CI þ Vehicle groups were similar
(P > 0.05).
3.3. rhTrx-1 enhanced proliferation of cultured NSCs
To investigate the direct effects of rhTrx-1 on NSCs and to study
the underlying mechanism, in vitro study was also conducted. As
shown in Fig. 4C, neurospheres and single cells expressed nestin, a
marker of NSCs. After treatment with different concentrations of
rhTrx-1 for 48 h, the percentage of BrdU labeled cells was higher in
10 and 100 mg/ml rhTrx-1 treatments compared to the vehicle
group, while less BrdU positive cells were seen in the 500 mg/ml
treated group (Fig. 4A, D; P< 0.01). The results of Ki67 staining also
revealed that rhTrx-1 promoted proliferation of NSCs at concen-
trations of 10 and 100 mg/ml, but inhibited proliferation at 500 mg/
ml (Fig. 4B, E; P < 0.01).
3.4. rhTrx-1 promoted NSCs differentiating into neurons
After treatment with rhTrx-1 for 7 days, expression of Tuj1 and
GFAP were examined (Fig. 5A). Immunocytochemical results
revealed that the ratio of differentiated neurons was higher in
groups treated with both 1 mg/ml (13.51%) and 10 mg/ml (18.08%)
rhTrx-1 compared with the vehicle group (7.21%) (Fig. 5C; P < 0.05
at 1 mg/ml, P< 0.01 at 10 mg/ml). Western blot analysis showed thatFig. 6. The neurogenesis enhanced by rhTrx-1 was inhibited by U0126 in cultured NSCs. (A)
with vehicle or rhTrx-1 (10 mg/ml) for 2, 24, and 48 h. (B) Western blot analysis of expression
(C) Immunoﬂuorescence images and histograms showing the percentage of BrdU (green) po
(D) Immunoﬂuorescence images and percentage of Tuj1 (red) positive cells to all DAPI (blue
DMSO plus rhTrx-1 (rhTrx-1), U0126 dissolved in DMSO (U0126), and U0126 plus rhTrx-1 (rh
analysis. Scale bar: 50 mm. Data were analyzed by one-way ANOVA, followed by Tukey post-h
**P < 0.01 vs Vehicle group; #P < 0.05, ##P < 0.01 vs rhTrx-1 group.Tuj1 expression of NSCs in the 10 mg/ml treatment group was
increased approximately 1.5-fold compared to the vehicle group
(Fig. 5D, P < 0.05). The ratio of GFAP positive cells and the
expression of GFAP in NSCs were decreased when cells were
incubated in 10 mg/ml of rhTrx-1 (Fig. 5C, D; P < 0.05).3.5. Neurogenesis enhanced by rhTrx-1 was inhibited by U0126
Both MEK/ERK and PI3K/Akt signaling pathways have been
implicated in the mechanism of proliferation and neurogenesis of
NSCs. The activation of these pathways during rhTrx-1 treatment
and subsequent induction of proliferation and neurogenesis were
explored using a 10 mg/ml rhTrx-1 treatment to further study this
mechanism. Expression of phosphorylated ERK1/2 began to in-
crease at 2 h, maintain a high level to 48 h after rhTrx-1 adminis-
tration (Fig. 6A; P< 0.05 at 2 h, P< 0.01 at 24 h and 48 h). The levels
of phosphorylated Akt did not signiﬁcantly change after NSCs in-
cubation with rhTrx-1 (P > 0.05). Western blot analysis of the
protein sample, extracted from NSCs cultured for 48 h in prolifer-
ation medium revealed that pretreatment with the inhibitor of
ERK1/2 U0126 inhibited the elevation of the phosphorylated ERK1/
2 induced by rhTrx-1 (Fig. 6B; P < 0.01). Furthermore, U0126
suppressed increases in the ratio of BrdU labeled cells in the rhTrx-
1 treated group (Fig. 6C; P < 0.05). Also, co-administration with
U0126 decreased the percentage of neuronal differentiation
(Fig. 6D, P< 0.05) compared to levels observed in the rhTrx-1 group
(P < 0.01).4. Discussion
The prominent effects of rhTrx-1 treatment for improving
spatial learning and memory impairments in adult mice subjected
to global CI were demonstrated in the present study. Moreover,
rhTrx-1 was demonstrated to promote neurogenesis in the DG,
indicating that rhTrx-1 potentially plays a role in the induction of
neurogenesis and the facilitation of cognitive recovery following
ischemia of cerebral tissues in mice. The in vitro study of rhTrx-1 in
mice further demonstrated that the treatment also has the ability to
enhance NSC proliferation and differentiation to neural cells.
Furthermore, the ERK signaling pathway participated in stimulated
neurogenesis.
The hippocampus is associated with the processes of learning
and memory in mammals (Auer et al., 1989; Squire, 1992). In pre-
vious studies, it has been reported that 20 min of BCCAO treatment
can obliterate more than 50% of all hippocampal CA1 neurons
(Zhang et al., 2010), contributing to signiﬁcant learning impair-
ments visualized inmice byMWM testing (Block,1999; Raber et al.,
2004). With rhTrx-1 treatment, functional impairments resulting
from such ischemic periods were signiﬁcantly improved at post-
ischemic day 30, as demonstrated by both training and probe
trail testing results in the current study. These results suggest that
exogenous administration of rhTrx-1 may facilitate persistent
cognitive recovery following CI. Notably, mice treated with rhTrx-1
displayed equivalent swimming abilities during MWM testing and
equivalent locomotion activity during open-ﬁeld testing compared
to other groups. Therefore, the functional impairments in ischemicWestern blot analysis of expression of phosphorylated ERK1/2 and Akt in NSCs treated
of phosphorylated ERK1/2 in cultured NSCs after 2 d incubation with rhTrx-1 or U0126.
sitive cells to the total PI (red) stained cells after 2 d incubation with rhTrx-1 or U0126.
) stained cells after 7d rhTrx-1 or U0126 incubation. Cells treated with DMSO (vehicle),
Trx-1þU0126), respectively, for 2 d or 7 d according to proliferation and differentiation
oc test and expressed as mean  S.E.M. from 5 wells per treatment condition. *P < 0.05,
L. Tian et al. / Neuropharmacology 77 (2014) 453e464462animals during the MWM testing may be partially or completely
caused by deﬁcits in task learning. These tests do, however
demonstrate that these deﬁcits are not related to limitations of
normal motor functions.
A considerable degree of neurogenesis from endogenous pre-
cursors has been reported to occur following CI in the adult
mammalian brain, as documented in various rodent models (Jin
et al., 2001; Kee et al., 2001; Liu et al., 1998). This observation
suggests the possibility that neuronal cells genesis might provide
an alternative mechanism for post-ischemic functional recovery
(Arvidsson et al., 2002; Carmichael, 2006; Hermann and Chopp,
2012). Neurogenesis occurs in 2 sites in the brain of adult mam-
mals, the SGZ and the subventricular zone (SVZ) of the lateral
ventricle. These regions comprise the entire capacity of neuro-
genesis throughout an animal’s life (Cameron and McKay, 2001;
Kempermann et al., 2004). The survival rate of adult neural pre-
cursor cells in the ischemic brain, however, is very poor. In fact,
only a small percentage of these cells successfully differentiate
into new neurons (Zhang et al., 2004, 2011). Thus, numerous
therapeutic intervention strategies have been designed with the
goal of promoting endogenous neurogenesis and subsequent
survival of implanted neural stem cells (Bartolini et al., 2011; Wei
et al., 2012). The current results demonstrate that administration
of rhTrx-1 exerted signiﬁcant proliferative effects on hippocampal
precursors. Combined with previous reports, these ﬁndings may
indicate that the cellular mechanisms underlying the protective
effects of rhTrx-1 may vary during different reperfusion stages
following ischemia. In early stages following ischemia, rhTrx-1
may reduce apoptotic death, thus exerting neuronal protection
(Ma et al., 2012). During late stages, rhTrx-1 may increase gen-
eration and survival of new neurons in the hippocampus. In the
adult mouse hippocampus, newly generated neural cells are
functionally integrated into the hippocampal circuitry by 4 weeks
and display passive membrane properties, action potentials, and
functional synaptic inputs similar to those found in mature den-
tate granule cells (van Praag et al., 2002). Considering these ob-
servations, functional recovery at 4 weeks after rhTrx-1
administration may be attributable to the neurogenesis promo-
tion effects of rhTrx-1. The current histological and Western blot
results also conﬁrm that neural cell proliferation was markedly
increased after administration of 10 mg/ml rhTrx-1. Similarly,
differentiation of NSCs into neurons was also stimulated in
cultured cells in the present study. However, we noticed that
administration of much higher concentration of rhTrx-1 (500 mg/
ml) showed an inhibiting action on the proliferation of cultured
neural stem cells inversely, indicating a bell shape effect of rhTrx-
1 on proliferation. Interestingly, it has been reported that the
chemotactic effect of rhTrx-1 on human PMNs and T cells is also
manifested as a typical bell-shaped doseeresponse curve (Bertini
et al., 1999). Based on these data, it may be tentatively concluded
that rhTrx-1 facilitates cell repair in hippocampus through stim-
ulation of neurogenesis by endogenous progenitor cells, thus
improving behavioral recovery. Although these results provide
evidence supporting the hypothesis that neurogenesis contributes
to the neuroprotective effects of rhTrx-1 following ischemic injury
in brain tissues, the possibility that other potential effects of
rhTrx-1 are also involved in the recovery of behavior cannot be
excluded.
Both the MEK/ERK and PI3K/Akt signaling pathways participate
in neurogenesis following cerebral ischemia (Kilic et al., 2006;
Shioda et al., 2009). The ERK signaling cascade is reported to con-
trol the proliferation of multiple cell types, including neural stem/
progenitor cells, especially in response to growth factor treatment
(Li et al., 2001; Wang et al., 2009). The current study revealed that
administration of rhTrx-1 increased the level of activated ERK1/2.These ﬁndings were conﬁrmed by abolishment of rhTrx1-induced
proliferation when the ERK signaling pathway was blocked by
U0126, also dramatically reducing expression of the neuronal
marker Tuj1. Although accumulating evidence supports the effect of
the PI3K/Akt signaling pathway in cell cycle regulation (Liang and
Slingerland, 2003), stem cell self-renewal, and neuronal cell num-
ber and composition (Easton et al., 2005; Tschopp et al., 2005), no
signiﬁcant changes in pAkt level were reported inmice treatedwith
rhTrx-1. Cumulatively, these data suggest that the ERK signaling
pathway is necessary for regulation of proliferation and differenti-
ation in NSCs treated with rhTrx-1. The potential role of rhTrx-1 in
the activation of the ERK signaling pathway, however, was not
determined by this study. Recent evidence has demonstrated that
vascular endothelial growth factor (VEGF) has a broad range of
neurotropic and neuroprotective effects in the central nervous
system (CNS) (Ruiz de Almodovar et al., 2009), where it stimulates
self-renewal of both embryonic and adult NSCs through the MEK/
ERK and PI3K/Akt signaling pathways (Fournier et al., 2012; Shen
et al., 2004). Conversely, Trx1 is able to regulate VEGF levels in
both embryonic and adult neural stem cells under either normoxic
or hypoxic conditions, thus promoting angiogenesis by acting on
hypoxia inducible factor 1a (HIF-1a) (Welsh et al., 2002). Therefore,
rhTrx-1 is possibly both a neurogenic and angiogenic factor, pro-
moting neurogenesis through the ERK signaling pathway in the CNS.
Neural stem cells play a pivotal role in self-renewal, potentially
differentiating into various different cytotypes (Doe, 2008;
Shimazaki and Okano, 2008). Neurogenesis in the SGZ has been
shown to be related to exercise, spatial learning, and memory
(Gould et al., 1999; van Praag et al., 1999). Moreover, active neu-
rogenesis is crucial for injury repair to morphological changes in
the hippocampus caused by neuron loss associated with either
ischemia or neurodegenerative diseases, such as Alzheimer’s dis-
ease, rheumatoid arthritis and stroke, or trauma (Ramirez-Ruiz
et al., 2005; Wang et al., 2001). Therefore, development of new
drugs and treatments to promote neurogenesis may enable
replenishment of lost neurons, providing a promising strategy for
treatment of these neurodegenerative diseases. In fact, several
neuronal growth factors have been demonstrated to promote
neurogenesis, as previously described. In addition, recent evidence
has demonstrated the importance of the relationship between
neural stem/progenitor cells and vasculature (Louissaint et al.,
2002; Palmer et al., 2000; Shen et al., 2004). Cumulatively, these
ﬁndings provide compelling evidence for the coordination of
angiogenesis and neurogenesis in the CNS; however, clinical
application remains limited by low bioavailability and the limited
capacity of most drug therapies to cross the bloodebrain barrier.
Trx1 is a small redox protein present in many organisms, where it
plays a role in important biological processes and endothelial cells
angiogenesis. Moreover, Trx1 crosses the bloodebrain barrier. Thus,
rhTrx-1 exhibits favorable pharmacokinetics and a good safety
proﬁle for human applications, making it a prime candidate for
angiogenesis and neurogenesis mediation in developing and adult
brains.
The current study clearly demonstrates that rhTrx-1 is effective
in promoting neurogenesis in the dentate gyrus and facilitating
cognitive recovery following CI in adult mice. Additionally, the
underlying mechanism of rhTrx-1 in neurogenesis was conﬁrmed
to be mediated by the ERK signaling pathway. These results suggest
that rhTrx-1 may be a potential agent for the clinical treatment of
ischemic injury in brain tissues.
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